N-acetyl cysteine treatment mitigates biomarkers of oxidative stress in different tissues of bile duct ligated rats

References

• Ahmadi, N., Ghanbarinejad, V., Ommati, M. M., Jamshidzadeh, A., & Heidari, R. (2018). Taurine prevents mitochondrial membrane permeabilization and swelling upon interaction with manganese: Implication in the treatment of cirrhosis-associated central nervous system complications. Journal of Biochemical and Molecular Toxicology, 32(11), e22216. https://doi.org/10.1002/jbt.22216
   PubMed Web of Science ®Google Scholar
• Alía, M., Horcajo, C., Bravo, L., & Goya, L. (2003). Effect of grape antioxidant dietary fiber on the total antioxidant capacity and the activity of liver antioxidant enzymes in rats. Nutrition Research, 23(9), 1251–1267. https://doi.org/10.1016/S0271-5317(03)00131-3
   Web of Science ®Google Scholar
• Arakawa, M., & Ito, Y. (2007). N-acetylcysteine and neurodegenerative diseases: Basic and clinical pharmacology. Cerebellum (London, England), 6(4), 308–314. https://doi.org/10.1080/14734220601142878
   PubMed Web of Science ®Google Scholar
• Arduini, A., Serviddio, G., Tormos, A. M., Monsalve, M., & Sastre, J. (2012). Mitochondrial dysfunction in cholestatic liver diseases. Frontiers in bioscience (Elite Edition), 4, 2233–2252. https://doi.org/10.2741/539
   PubMedGoogle Scholar
• Assimakopoulos, S. F., Maroulis, I., Patsoukis, N., Vagenas, K., Scopa, C. D., Georgiou, C. D., & Vagianos, C. E. (2007). Effect of antioxidant treatments on the gut-liver axis oxidative status and function in bile duct-ligated rats. World Journal of Surgery, 31(10), 2023–2032. https://doi.org/10.1007/s00268-007-9191-3
   PubMed Web of Science ®Google Scholar
• Attili, A. F., Angelico, M., Cantafora, A., Alvaro, D., & Capocaccia, L. (1986). Bile acid-induced liver toxicity: Relation to the hydrophobic-hydrophilic balance of bile acids. Medical Hypotheses, 19(1), 57–69. https://doi.org/10.1016/0306-9877(86)90137-4
   PubMed Web of Science ®Google Scholar
• Babior, B. M. (2000). Phagocytes and oxidative stress. The American Journal of Medicine, 109(1), 33–44. https://doi.org/10.1016/S0002-9343(00)00481-2
   PubMed Web of Science ®Google Scholar
• Bosoi, C. R., Oliveira, M. M., Ochoa-Sanchez, R., Tremblay, M., Ten Have, G. A., Deutz, N. E., Rose, C. F., & Bemeur, C. (2017). The bile duct ligated rat: A relevant model to study muscle mass loss in cirrhosis. Metabolic Brain Disease, 32(2), 513–518. https://doi.org/10.1007/s11011-016-9937-4
   PubMed Web of Science ®Google Scholar
• Butterworth, R. F. (2011). Hepatic encephalopathy: a central neuroinflammatory disorder? Hepatology (Baltimore, Md.), 53(4), 1372–1376. https://doi.org/10.1002/hep.24228
   PubMed Web of Science ®Google Scholar
• Chen, C.-C., Ho, C.-Y., Chaung, H.-C., Tain, Y.-L., Hsieh, C.-S., Kuo, F.-Y., Yang, C.-Y., & Huang, L.-T. (2013). Fish omega-3 fatty acids induce liver fibrosis in the treatment of bile duct-ligated rats. Digestive Diseases and Sciences, 58(2), 440–447. https://doi.org/10.1007/s10620-012-2489-5
   PubMed Web of Science ®Google Scholar
• Copple, B. L., Jaeschke, H., & Klaassen, C. D. (2010). Oxidative stress and the pathogenesis of cholestasis. Seminars in Liver Disease, 30(2), 195–204. https://doi.org/10.1055/s-0030-1253228
   PubMed Web of Science ®Google Scholar
• Cotgreave, I. A. (1996). N-acetylcystei ne: Pharmacological considerations and experimental and clinical applications. In H. Sies (Ed.), Advances in pharmacology (Vol. 38, pp. 205–227). Academic Press.
   Google Scholar
• Eftekhari, A., Ahmadian, E., Panahi-Azar, V., Hosseini, H., Tabibiazar, M., & Dizaj, S. M. (2018). Hepatoprotective and free radical scavenging actions of quercetin nanoparticles on aflatoxin B1-induced liver damage: In vitro/in vivo studies. Artificial Cells, Nanomedicine, and Biotechnology, 46(2), 411–420. https://doi.org/10.1080/21691401.2017.1315427
   PubMed Web of Science ®Google Scholar
• Elbini Dhouib, I., Jallouli, M., Annabi, A., Gharbi, N., Elfazaa, S., & Lasram, M. M. (2016). A minireview on N-acetylcysteine: An old drug with new approaches. Life Sciences, 151, 359–363. https://doi.org/10.1016/j.lfs.2016.03.003
   PubMed Web of Science ®Google Scholar
• Fickert, P., Krones, E., Pollheimer, M. J., Thueringer, A., Moustafa, T., Silbert, D., Halilbasic, E., Yang, M., Jaeschke, H., Stokman, G., Wells, R. G., Eller, K., Rosenkranz, A. R., Eggertsen, G., Wagner, C. A., Langner, C., Denk, H., & Trauner, M. (2013). Bile acids trigger cholemic nephropathy in common bile-duct-ligated mice. Hepatology (Baltimore, Md.), 58(6), 2056–2069. https://doi.org/10.1002/hep.26599
   PubMed Web of Science ®Google Scholar
• Fouts, D. E., Torralba, M., Nelson, K. E., Brenner, D. A., & Schnabl, B. (2012). Bacterial translocation and changes in the intestinal microbiome in mouse models of liver disease. Journal of Hepatology, 56(6), 1283–1292. https://doi.org/10.1016/j.jhep.2012.01.019
   PubMed Web of Science ®Google Scholar
• Fries, G. R., & Kapczinski, F. (2011). N-acetylcysteine as a mitochondrial enhancer: a new class of psychoactive drugs? Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999), 33(4), 321–322. https://doi.org/10.1590/S1516-44462011000400003
   PubMed Web of Science ®Google Scholar
• García-Estañ, J., Ortiz, M. C., & Lee, S. S. (2002). Nitric oxide and renal and cardiac dysfunction in cirrhosis. Clinical Science (London, England : 1979), 102(2), 213–222. https://doi.org/10.1042/cs1020213
   PubMed Web of Science ®Google Scholar
• Görg, B., Qvartskhava, N., Bidmon, H.-J., Palomero-Gallagher, N., Kircheis, G., Zilles, K., & Häussinger, D. (2010). Oxidative stress markers in the brain of patients with cirrhosis and hepatic encephalopathy. Hepatology (Baltimore, Md.), 52(1), 256–265. https://doi.org/10.1002/hep.23656
   PubMed Web of Science ®Google Scholar
• Gupta, R., Dubey, D. K., Kannan, G. M., & Flora, S. J. S. (2007). Concomitant administration of Moringa oleifera seed powder in the remediation of arsenic-induced oxidative stress in mouse. Cell Biology International, 31(1), 44–56. https://doi.org/10.1016/j.cellbi.2006.09.007
   PubMed Web of Science ®Google Scholar
• Heard, K. J. (2008). Acetylcysteine for acetaminophen poisoning. The New England Journal of Medicine, 359(3), 285–292. https://doi.org/10.1056/NEJMct0708278
   PubMed Web of Science ®Google Scholar
• Heidari, R., & Niknahad, H. (2019). The role and study of mitochondrial impairment and oxidative stress in cholestasis. In M. Vinken (Ed.), Experimental cholestasis research (pp. 117–132). Springer New York.
   Google Scholar
• Heidari, R., Babaei, H., & Eghbal, M. A. (2013). Cytoprotective effects of organosulfur compounds against methimazole induced toxicity in isolated rat hepatocytes. Advanced Pharmaceutical Bulletin, 3(1), 135–142. https://doi.org/10.5681/apb.2013.023
   PubMedGoogle Scholar
• Heidari, R., Ghanbarinejad, V., Mohammadi, H., Ahmadi, A., Esfandiari, A., Azarpira, N., & Niknahad, H. (2018a). Dithiothreitol supplementation mitigates hepatic and renal injury in bile duct ligated mice: Potential application in the treatment of cholestasis-associated complications. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 99, 1022–1032. https://doi.org/10.1016/j.biopha.2018.01.018
   PubMed Web of Science ®Google Scholar
• Heidari, R., Ghanbarinejad, V., Mohammadi, H., Ahmadi, A., Esfandiari, A., Azarpira, N., & Niknahad, H. (2018b). Dithiothreitol supplementation mitigates hepatic and renal injury in bile duct ligated mice: Potential application in the treatment of cholestasis-associated complications. Biomedicine and Pharmacotherapy, 99, 1022–1032. https://doi.org/10.1016/j.biopha.2018.01.018
   Google Scholar
• Heidari, R., Ghanbarinejad, V., Ommati, M. M., Jamshidzadeh, A., & Niknahad, H. (2018). Mitochondria protecting amino acids: Application against a wide range of mitochondria-linked complications. PharmaNutrition, 6(4), 180–190. https://doi.org/10.1016/j.phanu.2018.09.001
   Google Scholar
• Heidari, R., Jamshidzadeh, A., Ghanbarinejad, V., Ommati, M. M., & Niknahad, H. (2018). Taurine supplementation abates cirrhosis-associated locomotor dysfunction. Clinical and Experimental Hepatology, 4(2), 72–82. https://doi.org/10.5114/ceh.2018.75956
   PubMed Web of Science ®Google Scholar
• Heidari, R., Jamshidzadeh, A., Niknahad, H., Mardani, E., Ommati, M. M., Azarpira, N., Khodaei, F., Zarei, A., Ayarzadeh, M., Mousavi, S., Abdoli, N., Yeganeh, B. S., Saeedi, A., & Najibi, A. (2016). Effect of taurine on chronic and acute liver injury: Focus on blood and brain ammonia. Toxicology Reports, 3, 870–879. https://doi.org/10.1016/j.toxrep.2016.04.002
   PubMed Web of Science ®Google Scholar
• Heidari, R., Moezi, L., Asadi, B., Ommati, M. M., & Azarpira, N. (2017). Hepatoprotective effect of boldine in a bile duct ligated rat model of cholestasis/cirrhosis. PharmaNutrition, 5(3), 109–117. https://doi.org/10.1016/j.phanu.2017.07.001
   Google Scholar
• Heidari, R., Mohammadi, H., Ghanbarinejad, V., Ahmadi, A., Ommati, M. M., Niknahad, H., Jamshidzadeh, A., Azarpira, N., & Abdoli, N. (2018). Proline supplementation mitigates the early stage of liver injury in bile duct ligated rats. Journal of Basic and Clinical Physiology and Pharmacology, 30(1), 91–101. https://doi.org/10.1515/jbcpp-2017-0221
   PubMedGoogle Scholar
• Heidari, R., Niknahad, H., Sadeghi, A., Mohammadi, H., Ghanbarinejad, V., Ommati, M. M., Hosseini, A., Azarpira, N., Khodaei, F., Farshad, O., Rashidi, E., Siavashpour, A., Najibi, A., Ahmadi, A., & Jamshidzadeh, A. (2018). Betaine treatment protects liver through regulating mitochondrial function and counteracting oxidative stress in acute and chronic animal models of hepatic injury. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 103, 75–86. https://doi.org/10.1016/j.biopha.2018.04.010
   PubMed Web of Science ®Google Scholar
• Hirschfield, G. M., Heathcote, E. J., & Gershwin, M. E. (2010). Pathogenesis of cholestatic liver disease and therapeutic approaches. Gastroenterology, 139(5), 1481–1496. https://doi.org/10.1053/j.gastro.2010.09.004
   PubMed Web of Science ®Google Scholar
• Holt, S., Marley, R., Fernando, B., Harry, D., Anand, R., Goodier, D., & Moore, K. (1999). Acute cholestasis-induced renal failure: Effects of antioxidants and ligands for the thromboxane A2 receptor. Kidney International, 55(1), 271–277. https://doi.org/10.1046/j.1523-1755.1999.00252.x
   PubMed Web of Science ®Google Scholar
• Huang, L.-T., Tiao, M.-M., Tain, Y.-L., Chen, C.-C., & Hsieh, C.-S. (2009). Melatonin ameliorates bile duct ligation-induced systemic oxidative stress and spatial memory deficits in developing Rats. Pediatric Research, 65(2), 176–180. https://doi.org/10.1203/PDR.0b013e31818d5bc7
   PubMed Web of Science ®Google Scholar
• Jamshidzadeh, A., Heidari, R., Latifpour, Z., Ommati, M. M., Abdoli, N., Mousavi, S., Azarpira, N., Zarei, A., Zarei, M., Asadi, B., Abasvali, M., Yeganeh, Y., Jafari, F., Saeedi, A., Najibi, A., & Mardani, E. (2017a). Carnosine ameliorates liver fibrosis and hyperammonemia in cirrhotic rats. Clinics and Research in Hepatology and Gastroenterology, 41(4), 424–434. https://doi.org/10.1016/j.clinre.2016.12.010
   PubMed Web of Science ®Google Scholar
• Jamshidzadeh, A., Heidari, R., Latifpour, Z., Ommati, M. M., Abdoli, N., Mousavi, S., Azarpira, N., Zarei, A., Zarei, M., Asadi, B., Abasvali, M., Yeganeh, Y., Jafari, F., Saeedi, A., Najibi, A., & Mardani, E. (2017b). Carnosine ameliorates liver fibrosis and hyperammonemia in cirrhotic rats. Clinics and Research in Hepatology and Gastroenterology, 41(4), 424–434. https://doi.org/10.1016/j.clinre.2016.12.010
   PubMed Web of Science ®Google Scholar
• Jamshidzadeh, A., Heidari, R., Mohammadi-Samani, S., Azarpira, N., Najbi, A., Jahani, P., & Abdoli, N. (2015). A comparison between the nephrotoxic profile of gentamicin and gentamicin nanoparticles in mice. Journal of Biochemical and Molecular Toxicology, 29(2), 57–62. https://doi.org/10.1002/jbt.21667
   PubMed Web of Science ®Google Scholar
• Jüngst, C., & Lammert, F. (2013). Cholestatic liver disease. Digestive Diseases (Basel, Switzerland)), 31(1), 152–154. https://doi.org/10.1159/000347210
   PubMed Web of Science ®Google Scholar
• Katalinic, V., Modun, D., Music, I., & Boban, M. (2005). Gender differences in antioxidant capacity of rat tissues determined by 2,2'-azinobis (3-ethylbenzothiazoline 6-sulfonate; ABTS) and ferric reducing antioxidant power (FRAP) assays . Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP, 140(1), 47–52. https://doi.org/10.1016/j.cca.2005.01.005
   PubMed Web of Science ®Google Scholar
• Khansari, N., Shakiba, Y., & Mahmoudi, M. (2009). Chronic inflammation and oxidative stress as a major cause of age-related diseases and cancer. Recent Patents on Inflammation & Allergy Drug Discovery, 3(1), 73–80. https://doi.org/10.2174/187221309787158371
   PubMedGoogle Scholar
• Krones, E., Wagner, M., Eller, K., Rosenkranz, A. R., Trauner, M., & Fickert, P. (2015). Bile acid-induced cholemic nephropathy. Digestive Diseases (Basel, Switzerland), 33(3), 367–375. https://doi.org/10.1159/000371689
   PubMed Web of Science ®Google Scholar
• Kumar, D., & Tandon, R. K. (2001). Use of ursodeoxycholic acid in liver diseases. Journal of Gastroenterology and Hepatology, 16(1), 3–14. https://doi.org/10.1046/j.1440-1746.2001.02376.x
   PubMed Web of Science ®Google Scholar
• Lasram, M. M., Dhouib, I. B., Annabi, A., El Fazaa, S., & Gharbi, N. (2015). A review on the possible molecular mechanism of action of N-acetylcysteine against insulin resistance and type-2 diabetes development. Clinical Biochemistry, 48(16–17), 1200–1208. https://doi.org/10.1016/j.clinbiochem.2015.04.017
   PubMed Web of Science ®Google Scholar
• Levine, R. L., Garland, D., Oliver, C. N., Amici, A., Climent, I., Lenz, A.-G., Ahn, B.-W., Shaltiel, S., & Stadtman, E. R. (1990). Determination of carbonyl content in oxidatively modified proteins. Methods in Enzymology, 186, 464–478. https://doi.org/10.1016/0076-6879(90)86141-H
   PubMed Web of Science ®Google Scholar
• Levy, C. (2013). Cholestatic liver diseases, an issue of clinics in liver disease. Elsevier Health Sciences. https://doi.org/10.1016/j.cld.2013.01.001
   Google Scholar
• Li, T., & Chiang, J. Y. L. (2017). Bile acid-induced liver injury in cholestasis. In W.-X. Ding & X.-M. Yin (Eds.), Cellular injury in liver diseases (pp. 143–172).Springer International Publishing.
   Google Scholar
• Lino, M., Binaut, R., Noël, L.-H., Patey, N., Rustin, P., Daniel, L., Serpaggi, J., Varaut, A., Vanhille, P., Knebelmann, B., Grünfeld, J.-P., & Fakhouri, F. (2005). Tubulointerstitial nephritis and fanconi syndrome in primary biliary cirrhosis. American Journal of Kidney Diseases : The Official Journal of the National Kidney Foundation, 46(3), e41–e46. https://doi.org/10.1053/j.ajkd.2005.05.021
   PubMed Web of Science ®Google Scholar
• Ljubuncic, P., Tanne, Z., & Bomzon, A. (2000). Evidence of a systemic phenomenon for oxidative stress in cholestatic liver disease. Gut, 47(5), 710–716. https://doi.org/10.1136/gut.47.5.710
   PubMed Web of Science ®Google Scholar
• Malik, S. G., Irwanto, K. A., Ostrow, J. D., & Tiribelli, C. (2010). Effect of bilirubin on cytochrome c oxidase activity of mitochondria from mouse brain and liver. BMC Research Notes, 3, 162. https://doi.org/10.1186/1756-0500-3-162
   PubMedGoogle Scholar
• Martínez-Cecilia, D., Reyes-Díaz, M., Ruiz-Rabelo, J., Gomez-Alvarez, M., Villanueva, C. M., Álamo, J., Muntané, J., & Padillo, F. J. (2016). Oxidative stress influence on renal dysfunction in patients with obstructive jaundice: A case and control prospective study. Redox Biology, 8, 160–164. https://doi.org/10.1016/j.redox.2015.12.009
   PubMed Web of Science ®Google Scholar
• Marullo, R., Werner, E., Degtyareva, N., Moore, B., Altavilla, G., Ramalingam, S. S., & Doetsch, P. W. (2013). Cisplatin induces a mitochondrial-ROS response that contributes to cytotoxicity depending on mitochondrial redox status and bioenergetic functions. PLoS One, 8(11), e81162. https://doi.org/10.1371/journal.pone.0081162
   PubMed Web of Science ®Google Scholar
• Meeks, R. G., & Harrison, S. (1991). Hepatotoxicology. CRC Press.
   Google Scholar
• Mokhtari, V., Afsharian, P., Shahhoseini, M., Kalantar, S. M., & Moini, A. (2017). A review on various uses of N-acetyl cysteine. Cell Journal, 19(1), 11–17. https://doi.org/10.22074/cellj.2016.4872
   PubMed Web of Science ®Google Scholar
• Mormone, E., George, J., & Nieto, N. (2011). Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches. Chemico-Biological Interactions, 193(3), 225–231. https://doi.org/10.1016/j.cbi.2011.07.001
   PubMed Web of Science ®Google Scholar
• Mustafa, M. G., Cowger, M. L., & King, T. E. (1969). Effects of bilirubin on mitochondrial reactions. The Journal of Biological Chemistry, 244(23), 6403–6414. doi:
   PubMed Web of Science ®Google Scholar
• Niknahad, H., Heidari, R., Alzuhairi, A. M., & Najibi, A. (2015). Mitochondrial dysfunction as a mechanism for pioglitazone-induced injury toward HepG2 cell line. Pharmaceutical Sciences, 20, 169–174. https://doi.org/10.5681/PS.2015.007
   Google Scholar
• Niknahad, H., Jamshidzadeh, A., Heidari, R., Zarei, M., & Ommati, M. M. (2017). Ammonia-induced mitochondrial dysfunction and energy metabolism disturbances in isolated brain and liver mitochondria, and the effect of taurine administration: Relevance to hepatic encephalopathy treatment. Clinical and Experimental Hepatology, 3, 141–151. https://doi.org/10.5114/ceh.2017.68833
   PubMed Web of Science ®Google Scholar
• O’Brien, A., China, L., Massey, K. A., Nicolaou, A., Winstanley, A., Newson, J., Hobbs, A., Audzevich, T., & Gilroy, D. W. (2016). Bile duct-ligated mice exhibit multiple phenotypic similarities to acute decompensation patients despite histological differences . Liver International: Official Journal of the International Association for the Study of the Liver, 36(6), 837–846. https://doi.org/10.1111/liv.12876
   PubMed Web of Science ®Google Scholar
• Ohara, M., Ogawa, K., Suda, G., Kimura, M., Maehara, O., Shimazaki, T., Suzuki, K., Nakamura, A., Umemura, M., Izumi, T., Kawagishi, N., Nakai, M., Sho, T., Natsuizaka, M., Morikawa, K., Ohnishi, S., & Sakamoto, N. (2018). L-carnitine suppresses loss of skeletal muscle mass in patients with liver cirrhosis. Hepatology Communications, 2(8), 910–922. https://doi.org/10.1002/hep4.1207
   Web of Science ®Google Scholar
• Ommati, M. M., Heidari, R., Ghanbarinejad, V., Abdoli, N., & Niknahad, H. (2019). Taurine treatment provides neuroprotection in a mouse model of manganism. Biological Trace Element Research, 190(2), 384–395. https://doi.org/10.1007/s12011-018-1552-2
   PubMed Web of Science ®Google Scholar
• Ommati, M. M., Heidari, R., Jamshidzadeh, A., Zamiri, M. J., Sun, Z., Sabouri, S., Wang, J., Ahmadi, F., Javanmard, N., Seifi, K., Mousapour, S., & Yeganeh, B. S. (2018). Dual effects of sulfasalazine on rat sperm characteristics, spermatogenesis, and steroidogenesis in two experimental models. Toxicology Letters, 284, 46–55. https://doi.org/10.1016/j.toxlet.2017.11.034
   PubMed Web of Science ®Google Scholar
• Ommati, M. M., Jamshidzadeh, A., Niknahad, H., Mohammadi, H., Sabouri, S., Heidari, R., & Abdoli, N. (2017). N-acetylcysteine treatment blunts liver failure-associated impairment of locomotor activity. PharmaNutrition, 5(4), 141–147. https://doi.org/10.1016/j.phanu.2017.10.003
   Google Scholar
• Orellana, M., Rodrigo, R., Thielemann, L., & Guajardo, V. (2000). Bile duct ligation and oxidative stress in the rat: effects in liver and kidney. Comparative Biochemistry and Physiology Part C: Pharmacology, Toxicology and Endocrinology, 126(2), 105–111. https://doi.org/10.1016/S0742-8413(00)00102-X
   PubMed Web of Science ®Google Scholar
• Palmeira, C. M., & Rolo, A. P. (2004). Mitochondrially-mediated toxicity of bile acids. Toxicology, 203(1–3), 1–15. https://doi.org/10.1016/j.tox.2004.06.001
   PubMed Web of Science ®Google Scholar
• Pastor, A., Collado, P. S., Almar, M., & González-Gallego, J. (1997). Antioxidant enzyme status in biliary obstructed rats: effects of N-acetylcysteine. Journal of Hepatology, 27(2), 363–370. https://doi.org/10.1016/S0168-8278(97)80183-3
   PubMed Web of Science ®Google Scholar
• Paumgartner, G., & Beuers, U. (2002). Ursodeoxycholic acid in cholestatic liver disease: Mechanisms of action and therapeutic use revisited. Hepatology (Baltimore, Md.), 36(3), 525–531. https://doi.org/10.1053/jhep.2002.36088
   PubMed Web of Science ®Google Scholar
• Perez, M. J., & Briz, O. (2009). Bile-acid-induced cell injury and protection. World Journal of Gastroenterology, 15(14), 1677–1689. https://doi.org/10.3748/wjg.15.1677
   PubMed Web of Science ®Google Scholar
• Poli, G. (2000). Pathogenesis of liver fibrosis: Role of oxidative stress. Molecular Aspects of Medicine, 21(3), 49–98. https://doi.org/10.1016/S0098-2997(00)00004-2
   PubMedGoogle Scholar
• Poupon, R. (2010). Primary biliary cirrhosis: A 2010 update. Journal of Hepatology, 52(5), 745–758. https://doi.org/10.1016/j.jhep.2009.11.027
   PubMed Web of Science ®Google Scholar
• Rodrigues, C. M., Fan, G., Ma, X., Kren, B. T., & Steer, C. J. (1998). A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation. Journal of Clinical Investigation, 101(12), 2790–2799. https://doi.org/10.1172/JCI1325
   PubMed Web of Science ®Google Scholar
• Rolo, A. P., Oliveira, P. J., Moreno, A. J. M., & Palmeira, C. M. (2000). Bile acids affect liver mitochondrial bioenergetics: Possible relevance for cholestasis therapy. Toxicological Sciences : An Official Journal of the Society of Toxicology, 57(1), 177–185. https://doi.org/10.1093/toxsci/57.1.177
   PubMed Web of Science ®Google Scholar
• Rolo, A. P., Palmeira, C. M., & Wallace, K. B. (2003). Mitochondrially mediated synergistic cell killing by bile acids. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1637(1), 127–132. https://doi.org/10.1016/S0925-4439(02)00224-7
   PubMed Web of Science ®Google Scholar
• Romero-Gómez, M., Montagnese, S., & Jalan, R. (2015). Hepatic encephalopathy in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure. Journal of Hepatology, 62(2), 437–447. https://doi.org/10.1016/j.jhep.2014.09.005
   PubMed Web of Science ®Google Scholar
• Samuni, Y., Goldstein, S., Dean, O. M., & Berk, M. (2013). The chemistry and biological activities of N-acetylcysteine. Biochimica et Biophysica Acta, 1830(8), 4117–4129. https://doi.org/10.1016/j.bbagen.2013.04.016
   PubMed Web of Science ®Google Scholar
• Šebeková, K. n., Kupčová, V., Schinzel, R., & Heidland, A. (2002). Markedly elevated levels of plasma advanced glycation end products in patients with liver cirrhosis – amelioration by liver transplantation. Journal of Hepatology, 36(1), 66–71. https://doi.org/10.1016/S0168-8278(01)00232-X
   PubMed Web of Science ®Google Scholar
• Shafaroodi, H., Ebrahimi, F., Moezi, L., Hashemi, M., Doostar, Y., Ghasemi, M., & Dehpour, A. R. (2010). Cholestasis induces apoptosis in mice cardiac cells: The possible role of nitric oxide and oxidative stress. Liver International : official Journal of the International Association for the Study of the Liver, 30(6), 898–905. https://doi.org/10.1111/j.1478-3231.2010.02249.x
   PubMed Web of Science ®Google Scholar
• Sheen, J.-M., Huang, L.-T., Hsieh, C.-S., Chen, C.-C., Wang, J.-Y., & Tain, Y.-L. (2010). Bile duct ligation in developing rats: Temporal progression of liver, kidney, and brain damage. Journal of Pediatric Surgery, 45(8), 1650–1658. https://doi.org/10.1016/j.jpedsurg.2009.12.019
   PubMed Web of Science ®Google Scholar
• Shikata, F., Sakaue, T., Nakashiro, K-i., Okazaki, M., Kurata, M., Okamura, T., Okura, M., Ryugo, M., Nakamura, Y., Yasugi, T., Higashiyama, S., & Izutani, H. (2014). Pathophysiology of lung injury induced by common bile duct ligation in mice. PLoS One, 9(4), e94550. https://doi.org/10.1371/journal.pone.0094550
   PubMed Web of Science ®Google Scholar
• Silva, R. F. M., Rodrigues, C. l M. P., & Brites, D. (2001). Bilirubin-induced apoptosis in cultured rat neural cells is aggravated by chenodeoxycholic acid but prevented by ursodeoxycholic acid. Journal of Hepatology, 34(3), 402–408. https://doi.org/10.1016/S0168-8278(01)00015-0
   PubMed Web of Science ®Google Scholar
• Singh, S., Shackleton, G., Ah-Sing, E., Chakraborty, J., & Bailey, M. E. (1992). Antioxidant defenses in the bile duct-ligated rat. Gastroenterology, 103(5), 1625–1629. https://doi.org/10.1016/0016-5085(92)91187-9
   PubMed Web of Science ®Google Scholar
• Soares, J.-B., Pimentel-Nunes, P., Roncon-Albuquerque, R., & Leite-Moreira, A. (2010). The role of lipopolysaccharide/toll-like receptor 4 signaling in chronic liver diseases. Hepatology International, 4(4), 659–672. https://doi.org/10.1007/s12072-010-9219-x
   PubMed Web of Science ®Google Scholar
• Socci, D. J., Bjugstad, K. B., Jones, H. C., Pattisapu, J. V., & Arendash, G. W. (1999). Evidence that oxidative stress is associated with the pathophysiology of inherited hydrocephalus in the H-Tx rat model. Experimental Neurology, 155(1), 109–117. https://doi.org/10.1006/exnr.1998.6969
   PubMed Web of Science ®Google Scholar
• Sokol, R. J., Devereaux, M., Dahl, R., & Gumpricht, E. (2006). “Let there be bile”-understanding hepatic injury in cholestasis”– . Journal of pediatric gastroenterology and nutrition, 43 Suppl 1(Suppl 1), S4–S9. https://doi.org/10.1097/01.mpg.0000226384.71859.16
   PubMedGoogle Scholar
• Sun, Y., Pu, L.-Y., Lu, L., Wang, X.-H., Zhang, F., & Rao, J.-H. (2014). N-acetylcysteine attenuates reactive-oxygen-species-mediated endoplasmic reticulum stress during liver ischemia-reperfusion injury. World Journal of Gastroenterology, 20(41), 15289–15298. https://doi.org/10.3748/wjg.v20.i41.15289
   PubMed Web of Science ®Google Scholar
• Tag, C. G., Sauer-Lehnen, S., Weiskirchen, S., Borkham-Kamphorst, E., Tolba, R. H., Tacke, F., & Weiskirchen, R. (2015). Bile duct ligation in mice: Induction of inflammatory liver injury and fibrosis by obstructive cholestasis. Journal of Visualized Experiments, (96), 52438. https://doi.org/10.3791/52438
   Google Scholar
• Tag, C. G., Weiskirchen, S., Hittatiya, K., Tacke, F., Tolba, R. H., & Weiskirchen, R. (2015). Induction of experimental obstructive cholestasis in mice. Laboratory Animals, 49(1 Suppl), 70–80. https://doi.org/10.1177/0023677214567748
   PubMedGoogle Scholar
• Tahan, G., Tarcin, O., Tahan, V., Eren, F., Gedik, N., Sahan, E., Biberoglu, N., Guzel, S., Bozbas, A., Tozun, N., & Yucel, O. (2007). The effects of N-acetylcysteine on bile duct ligation-induced liver fibrosis in rats. Digestive Diseases and Sciences, 52(12), 3348–3354. https://doi.org/10.1007/s10620-006-9717-9
   PubMed Web of Science ®Google Scholar
• Truong, D. H., Eghbal, M. A., Hindmarsh, W., Roth, S. H., & O’Brien, P. J. (2006). Molecular mechanisms of hydrogen sulfide toxicity. Drug Metabolism Reviews, 38(4), 733–744. https://doi.org/10.1080/03602530600959607
   PubMed Web of Science ®Google Scholar
• van Slambrouck, C. M., Salem, F., Meehan, S. M., & Chang, A. (2013). Bile cast nephropathy is a common pathologic finding for kidney injury associated with severe liver dysfunction. Kidney International, 84(1), 192–197. https://doi.org/10.1038/ki.2013.78
   PubMed Web of Science ®Google Scholar
• Vaz, A. R., Delgado‐Esteban, M., Brito, M. A., Bolaños, J. P., Brites, D., & Almeida, A. (2010). Bilirubin selectively inhibits cytochrome c oxidase activity and induces apoptosis in immature cortical neurons: Assessment of the protective effects of glycoursodeoxycholic acid. Journal of Neurochemistry, 112(1), 56–65. https://doi.org/10.1111/j.1471-4159.2009.06429.x
   PubMed Web of Science ®Google Scholar
• Vinken, M. (2019). Experimental cholestasis research. Springer.
   Google Scholar
• Woolbright, B. L., & Jaeschke, H. (2012). Novel insight into mechanisms of cholestatic liver injury. World Journal of Gastroenterology, 18(36), 4985–4993. https://doi.org/10.3748/wjg.v18.i36.4985
   PubMed Web of Science ®Google Scholar
• Wright, D. J., Renoir, T., Smith, Z. M., Frazier, A. E., Francis, P. S., Thorburn, D. R., McGee, S. L., Hannan, A. J., & Gray, L. J. (2015). N-Acetylcysteine improves mitochondrial function and ameliorates behavioral deficits in the R6/1 mouse model of Huntington’s disease. Translational Psychiatry, 5, e492. https://doi.org/10.1038/tp.2014.131
   PubMed Web of Science ®Google Scholar
• Xiao, H., Wu, M., Shao, F., Guan, G., Huang, B., Tan, B., & Yin, Y. (2016). N-acetyl-L-cysteine protects the enterocyte against oxidative damage by modulation of mitochondrial function. Mediators of Inflammation, 2016, 1–9. https://doi.org/10.1155/2016/8364279
   Web of Science ®Google Scholar
• Yang, H., Ramani, K., Xia, M., Ko, K. S., Li, T. W. H., Oh, P., Li, J., & Lu, S. C. (2009). Dysregulation of glutathione synthesis during cholestasis in mice: Molecular mechanisms and therapeutic implications. Hepatology (Baltimore, Md.), 49(6), 1982–1991. https://doi.org/10.1002/hep.22908
   PubMed Web of Science ®Google Scholar
• Yang, Y.-Y., Lee, K.-C., Huang, Y.-T., Wang, Y.-W., Hou, M.-C., Lee, F.-Y., Lin, H.-C., & Lee, S.-D. (2008). Effects of N-acetylcysteine administration in hepatic microcirculation of rats with biliary cirrhosis. Journal of Hepatology, 49(1), 25–33. https://doi.org/10.1016/j.jhep.2008.02.012
   PubMed Web of Science ®Google Scholar
• Zhang, Y.-T., Zheng, Q.-S., Pan, J., & Zheng, R.-L. (2004). Oxidative damage of biomolecules in mouse liver induced by morphine and protected by antioxidants. Pharmacology and Toxicology, 95(2), 53–58. https://doi.org/10.1111/j.1742-7843.2004.950202.x
   Google Scholar